Suchergebnisse - "Gadgeel, Shirish"

PubPharm (356)

1

Brief Report: Prognostic relevance of 3q amplification in squamous cell carcinoma of the lung

enthalten in: bioRxiv.org | 2024

von Rous, F. | Li, P. | Carskadon, S. | +5

2

BUB1 inhibition sensitizes lung cancer cell lines to radiotherapy and chemoradiotherapy

enthalten in: bioRxiv.org | 2024

von Thoidingjam, S. | Sriramulu, S. | Hassan, O. | +5

3

Pembrolizumab Plus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1% : Pooled Analysis of Outcomes After 5 Years of Follow-Up

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Gadgeel, S. | Rodríguez-Abreu, D. | Halmos, B. | +7

4

Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations : ASCO Living Guideline, Version 2023.3

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Jaiyesimi, I. | Leighl, N. | Ismaila, N. | +21

5

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations : ASCO Living Guideline, Version 2023.3

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Jaiyesimi, I. | Leighl, N. | Ismaila, N. | +21

6

Trial Design and Optimal Determination of CNS Activity of Small Molecule Targeted Therapy in NSCLC

enthalten in: Clinical lung cancer | 2024

von Jennings, E. | Camidge, D. | Gadgeel, S. | +1

7

ALK Rearrangement Positive Lung Adenocarcinoma in Pregnancy Treated With Alectinib : A Case Report

enthalten in: Clinical lung cancer | 2024

von Gonzalez-Mosquera, L. | Rous, F. | Rogers, A. | +3

8

A Phase II Trial of Pevonedistat and Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

enthalten in: Clinical lung cancer | 2024

von Qin, A. | Wells, L. | Malhotra, B. | +5

9

Selective Personalized RadioImmunotherapy for Locally Advanced Non-Small-Cell Lung Cancer Trial (SPRINT)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Ohri, N. | Jolly, S. | Cooper, B. | +13

10

Frontline pembrolizumab monotherapy for metastatic non-small cell lung cancer with PD-L1 expression ≥50% : real-world outcomes in a US community oncology setting

enthalten in: Frontiers in oncology | 2024

von Gadgeel, S. | Rai, P. | Annavarapu, S. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[36]